News | RIVM

Predicting who will experience symptoms after Lyme disease remains challenging

Each year, approximately 27,000 people are diagnosed with Lyme disease. For most, the symptoms disappear after treatment with antibiotics. Unfortunately, 25% of those treated have chronic symptoms, such as fatigue, concentration disorders or pain.

Number of Lyme disease diagnoses remains high

In 2021, the number of Lyme disease diagnoses with a red ring or rash– known as an erythema migrans, or EM – remained as high as in the previous survey in 2017. GPs diagnosed 25,600 patients with a red ring or rash caused by the Lyme bacteria.

New test for Lyme disease is not reliable

To determine whether someone has Lyme disease, doctors in the Netherlands often use antibody tests. For some time now, so-called cellular tests have been available on the market.

Verschillende commerciële laboratoria gebruiken zogeheten cellulaire testen voor Lyme. Helaas zijn niet betrouwbaar.

Ten years of Tick Radar 80,000 tick bite reports; chances of being bitten highest in Drenthe

After recording 80,000 tick bites in 10 years via Tekenradar.nl, we now know that you are most likely to be bitten by a tick in Drenthe. Quickly removing the tick halves the chance of contracting Lyme disease.

Start cervical cancer screening on Saba

February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.

Breast cancer screening resumes on Bonaire after COVID-19 hiatus

Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.

Spread of tick-borne encephalitis virus in the Netherlands

Every year about 1.5 million ticks bite someone in the Netherlands, especially between March and October. Most people will not get sick of that.

Biosafety and Biosecurity on the Global Health Security Agenda

Since 2018, the Netherlands leads the way in the field of "Biosafety and Biosecurity" within the international Global Health Security Agenda (GHSA).

Global Infectious Disease Control hampered by the CBD Nagoya Protocol

So far, none of the models used by international networks of biobanks to arrange the legal responsibility under the CBD-Nagoya protocol works efficiently.

New test has no added value in Lyme disease of the central nervous system

Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.